Back to search

United States· US:84003-022_3c183adf-b20f-73aa-e063-6394a90adaa5

Dolce and Gabbana Everlast Foundation SPF 20 22N Medium

A medicinal product containing octisalate; octocrylene; titanium dioxide; zinc oxide, registered in United States by Dolce & Gabbana Beauty S.R.L.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDolce and Gabbana Everlast Foundation…ATC—REGISTER NO.US:84003-022_3c183adf…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE
Manufacturer
Dolce & Gabbana Beauty S.R.L
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    8400302200
    1 BOTTLE, PUMP in 1 CARTON (84003-022-00) / 27 mL in 1 BOTTLE, PUMP
  • ndc11
    8400302201
    1 BOTTLE, PUMP in 1 CARTON (84003-022-01) / 27 mL in 1 BOTTLE, PUMP
  • ndc11
    84003-022-00
  • ndc11
    84003-022-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Octisalate; octocrylene; titanium dioxide; zinc oxide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octisalate; octocrylene; titanium dioxide; zinc oxide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b7b944da-360c-4b12-8705-97a5f2547791
GET /v1/drugs/b7b944da-360c-4b12-8705-97a5f2547791?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "35; 50; 5; 18.8",
  "substance": "OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE",
  "productndc": "84003-022",
  "dosage_form": "EMULSION",
  "dea_schedule": null,
  "strength_unit": "mg/mL; mg/mL; mg/mL; mg/mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about octisalate; octocrylene; titanium dioxide; zinc oxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.